Imported fire ant rush desensitization using omalizumab and a premedication regimen

Ann Allergy Asthma Immunol. 2014 Nov;113(5):574-6. doi: 10.1016/j.anai.2014.08.007. Epub 2014 Sep 10.

Authors

Katherine S Tille¹, Amy L Parker²

Affiliations

¹ Department of Pediatrics, RAF Lakenheath Medical Center, Lakenheath, England.
² Department of Allergy and Immunology, Landstuhl Regional Medical Center, Landstuhl, Germany. Electronic address: Amy.parker.1@us.af.mil.

PMID: 25216971
DOI: 10.1016/j.anai.2014.08.007

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Animals
Ant Venoms / administration & dosage*
Anti-Allergic Agents / administration & dosage*
Antibodies, Anti-Idiotypic / administration & dosage*
Antibodies, Monoclonal, Humanized / administration & dosage*
Ants / immunology*
Desensitization, Immunologic / methods*
Female
Humans
Infant, Newborn
Omalizumab
Pregnancy
Pregnancy Complications / immunology
Pregnancy Complications / prevention & control

Substances

Ant Venoms
Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal, Humanized
Omalizumab